Several significantly changed genes at this timepoint have been associated with AD-like pathology and disease progression (BCL2L2, CHST8, CLEC7A, CYP27A, CYP7B1, DAPK1, GPR34, MERTK, OLFML3, SUMO1, TTR, TYROBP), cognitive impairment (DAPK1, EXO1, RELN, SUMO1, TYROBP), PD progression (SUMO1, MAPK10), and the accumulation of toxic proteins (DAPK1, MAPK10, MSR1, OLFML3, SUMO1, TYROBP). Here, BCL2L2 is linked to Parkinson disease.